Narayana Hrudayalaya DuPont analysis

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	0.81×	0.83×	0.85×	0.89×	0.81×
	0.82×	0.83×	0.94×	0.98×	0.99×
	13.6%	14.8%	18.2%	18.1%	16.7%
	0.80×	0.80×	0.85×	1.03×	1.24×
	2.75×	2.75×	2.00×	1.95×	1.95×
	19.8%	22.4%	24.5%	31.6%	32.4%
	19.7%	19.7%	24.3%	31.5%	33.5%

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

NH₹1,714.50

Narayana Hrudayalaya Ltd.

· Pharma & Health

₹ CrorePeersAPOLLOHOSP MAXHEALTH FORTIS NEULANDLAB NATCOPHARM LALPATHLAB SAILIFE COHANCEMcap ₹35,038 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×	0.81	0.89	0.85	0.83	0.81
Interest Burden (Pretax/EBIT) ×	0.99	0.98	0.94	0.83	0.82
EBIT Margin %	16.70	18.14	18.21	14.80	13.56
Asset Turnover ×	1.24	1.03	0.85	0.80	0.80
Financial Leverage (Assets/Equity) ×	1.95	1.95	2.00	2.75	2.75
ROE (5-step product, year-end total equity) %	32.44	31.60	24.54	22.44	19.79
ROE (owners' profit / average owners' equity) %	33.49	31.48	24.27	19.74	19.74

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.